Connor Clark & Lunn Investment Management Ltd. decreased its position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 20.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,357,875 shares of the health services provider's stock after selling 343,286 shares during the period. Connor Clark & Lunn Investment Management Ltd. owned 0.79% of Teladoc Health worth $12,343,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of the company. Jennison Associates LLC purchased a new position in shares of Teladoc Health during the third quarter valued at $1,544,000. Massachusetts Financial Services Co. MA grew its position in Teladoc Health by 477.1% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider's stock worth $3,397,000 after purchasing an additional 305,961 shares during the last quarter. Geode Capital Management LLC lifted its stake in Teladoc Health by 1.5% during the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider's stock worth $36,042,000 after purchasing an additional 56,864 shares during the period. Maple Rock Capital Partners Inc. bought a new position in shares of Teladoc Health during the third quarter valued at $11,291,000. Finally, Quantinno Capital Management LP raised its position in Teladoc Health by 190.4% in the 3rd quarter. Quantinno Capital Management LP now owns 186,143 shares of the health services provider's stock valued at $1,709,000 after purchasing an additional 122,050 shares during the last quarter. Institutional investors own 76.82% of the company's stock.
Teladoc Health Stock Performance
NYSE:TDOC traded up $0.09 during mid-day trading on Wednesday, reaching $8.48. The stock had a trading volume of 5,806,235 shares, compared to its average volume of 6,009,783. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The business has a 50 day simple moving average of $10.51 and a 200 day simple moving average of $9.74. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $15.68. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of -1.47 and a beta of 1.27.
Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. On average, analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of analysts have commented on the stock. Royal Bank of Canada lifted their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Oppenheimer reduced their price objective on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research note on Friday, January 24th. Bank of America boosted their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a "neutral" rating in a report on Wednesday, February 12th. The Goldman Sachs Group lowered their price objective on Teladoc Health from $16.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, March 3rd. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a report on Thursday, February 27th. Eleven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, Teladoc Health currently has a consensus rating of "Hold" and an average price target of $11.26.
View Our Latest Stock Analysis on Teladoc Health
About Teladoc Health
(
Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
